Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:BIOS

BioPlus Acquisition (BIOS) Stock Price, News & Analysis

BioPlus Acquisition logo

About BioPlus Acquisition Stock (NASDAQ:BIOS)

Advanced Chart

Key Stats

Today's Range
$10.79
$10.80
50-Day Range
$10.75
$10.84
52-Week Range
$10.05
$11.68
Volume
5,600 shs
Average Volume
122,781 shs
Market Capitalization
$209.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BioPlus Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. BioPlus Acquisition Corp. was incorporated in 2021 and is based in New York, New York.

Receive BIOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioPlus Acquisition and its competitors with MarketBeat's FREE daily newsletter.

BIOS Stock News Headlines

PayMate Plans to Acquire DigiAsia Bios
The Real Hillbilly Elegy
The mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky, Tennessee and beyond… It's one of our country’s most scenic areas. But hidden beneath the beauty is an ugly reality: our most beautiful land is also the poorest. It’s a tragedy because for over 200 years, generation after generation has worked “coal country” with nothing but a pick and shovel, hauling billions of dollars from the ground.
See More Headlines

BIOS Stock Analysis - Frequently Asked Questions

BioPlus Acquisition (BIOS) raised $180 million in an initial public offering (IPO) on Friday, December 3rd 2021. The company issued 18,000,000 shares at a price of $10.00 per share. Cantor served as the underwriter for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioPlus Acquisition investors own include TransMedics Group (TMDX), Deciphera Pharmaceuticals (DCPH) and BioMarin Pharmaceutical (BMRN).

Company Calendar

Today
2/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Industry
Holding & other investment offices
Sub-Industry
N/A
Current Symbol
NASDAQ:BIOS
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
14,990,000
Market Cap
$209.20 million
Optionable
Not Optionable
Beta
0.01
10 Best Stocks to Own in 2025 Cover

Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:BIOS) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners